Market Assessment
The study integrates60 structured interviews(qualitative deep dives) and300 online surveys(quantitative validation) with stakeholders across the KSA Medical Marijuana Market value chain — including healthcare providers, patients, and regulatory bodies. Coverage spans major cities and emerging regions.
| Customer Cohort | Description | Proposed Sample Size |
|---|---|---|
| Healthcare Professionals | Doctors and specialists prescribing medical marijuana | Sample Size: 80 |
| Patients | Individuals using medical marijuana for treatment | Sample Size: 100 |
| Regulatory Officials | Government representatives overseeing cannabis regulations | Sample Size: 30 |
| Pharmacy Owners | Pharmacies dispensing medical marijuana products | Sample Size: 50 |
| Researchers | Academics studying the effects of medical marijuana | Sample Size: 40 |
| Industry Experts | Consultants and analysts in the cannabis sector | Sample Size: 20 |
Total Respondents:320 (60 structured interviews+300 surveys)
The KSA Medical Marijuana Market is evolving, driven by increasing acceptance of cannabis for therapeutic use, rising chronic disease prevalence, and government support. Regulatory changes are facilitating market growth, while challenges like stigma and limited awareness persist.
Key growth drivers include the increasing acceptance of medical marijuana for therapeutic purposes, a rise in chronic diseases, expanded research on cannabis treatments, and supportive government regulations that encourage market development.
The market faces challenges such as societal stigma surrounding marijuana use, regulatory hurdles, limited awareness among healthcare professionals, and complexities in the supply chain that hinder effective distribution and access to products.
Opportunities include the development of new cannabis-based pharmaceuticals, potential for export to other markets, collaboration with healthcare providers for education, and growth in e-commerce for medical marijuana products, enhancing accessibility.
The market is segmented by type (e.g., dried flower, oils, edibles), end-user (hospitals, clinics, home care), region (Riyadh, Jeddah), application (pain management, neurological disorders), and distribution channel (pharmacies, online retail).
